Acumen Pharmaceuticals's total assets for Q2 2025 were $171.90M, a decrease of -15.93% from the previous quarter. ABOS total liabilities were $54.82M for the fiscal quarter, a 11.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.